Cancer Genetics Completes BioServe Buy | GenomeWeb

NEW YORK (GenomeWeb) – Cancer Genetics today announced the closing of its $1.9 million acquisition of Indian genomics and next-generation sequencing services company BioServe Biotechnologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.